The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

FDA Approves Vermillion’s Ovarian Cancer Test

By Global Cancer Consortium on September 12, 2009 • ( 1 Comment )

The U.S. Food and Drug Administration has approved a blood test to detect ovarian cancer and help physicians decide what kind of surgery should be done and by whom.

Sen. Kennedy Death Puts Focus On Brain Cancer

By Global Cancer Consortium on August 31, 2009 • ( 1 Comment )

Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy’s life, is one of the deadliest brain tumors that can occur in both adults and children.

The Key to Stopping Colon Cancer?

By Global Cancer Consortium on August 30, 2009 • ( Leave a comment )

Scientists in Switzerland may have found a way to inhibit the growth of colon cancer in humans, says a new study published in EMBO Molecular Medicine.

NeoPharm Tipped As Stock to Watch

By Global Cancer Consortium on August 24, 2009 • ( Leave a comment )

NeoPharm, a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha.

Power3 Medical Files for 3 Patents for Breast Cancer Test

By Global Cancer Consortium on August 22, 2009 • ( Leave a comment )

Power3 Medical Products, a company specializing in disease detection through the analysis of proteins, has filed for three patents on its blood test for the early detection of breast cancer.

Jennerex Raises $5.1 Million for Oncology Pipeline

By Global Cancer Consortium on August 15, 2009 • ( Leave a comment )

Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.

Dendreon to Build $70 Million Plant Near Atlanta

By Global Cancer Consortium on August 10, 2009 • ( Leave a comment )

The 160,000 square-foot facility could bring at least 300 jobs to Georgia.

New Software Brings Scientists Together

By Global Cancer Consortium on August 8, 2009 • ( Leave a comment )

Imagine thousands of scientists across the globe collaborating to find a cure for cancer, or create a new malaria vaccine.

Posts navigation

‹ Newer 1 … 62 63 64 65 66 67 68 69 70 71 72 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.